Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial

Authors: Jeffrey H. Lipton, Charles Chuah, Agnès Guerci‐Bresler, Gianantonio Rosti, David Simpson, Sarit Assouline, Gabriel Étienne, Franck E. Nicolini, Philipp le Coutre, Richard E Clark, Leif Stenke, David Andorsky, Vivian G. Oehler, Stephanie Lustgarten, Victor M. Rivera, Timothy Piers Clackson, Frank G. Haluska, Michele Baccarani, Jörge E. Cortes, François Guilhot, Andreas Hochhaus, Timothy P. Hughes, Hagop M. Kantarjian, Neil P. Shah, Moshe Talpaz, Michael Deininger - The Lancet 2016 cited by 259